On a new episode of CANCER BUZZ, CancerIQ's Feyi Olopade Ayodele (Feyi Olopade) shares how genetic healthcare services have adapted to virtual delivery, and what challenges face their widespread use after the current crisis. Tune in to the buzz! linktr.ee/cancerbuzz

On a new episode of CANCER BUZZ, CancerIQ's Feyi Olopade Ayodele (Feyi Olopade) shares how genetic healthcare services have adapted to virtual delivery, and what challenges face their widespread use after the current crisis. Tune in to the buzz! linktr.ee/cancerbuzz

.CancerIQ's Feyi Olopade Ayodele: Telehealth policy needs to be driven by the lessons we've learned from the pandemic... start with the services best suited to telehealth, supportive care services. #AMCCBS

Especially as more health systems try to close disparities #AMCCBS #AMCCBSvirtual

Proud of the leadership at Dignity Health for supporting their genetic counselors with the infrastructure needed to scale care #AMCCBS #AMCCBSvirtual

Truly honored to see @Hubspot profile the growth of our commercial team during the pandemic. Looking for a new opportunity? Join the team at CancerIQ! #digitalmarketing #enterprisesales #digitalhealth #demandgeneration bit.ly/2Olt08r

On this #internationalwomensday, I'd like to acknowledge and celebrate the inspiring women working day to day to help us accomplish our mission at CancerIQ #IWD2021 #ChooseToChallenge

“As a healthcare system, we need to dig deeper into what is driving higher colorectal cancer incidence and mortality in my community,” Feyi Olopade, CEO CancerIQ. linkedin.com/pulse/focusing… #genetics #ColorectalCancer

GCs generate $1.5m-$1.8m a year in downstream revenue. Find out how the team at Dignity Health is using CancerIQ to log genetically-tailored care plans, track outcomes and get credit for their contributions to the overall health system ACCC #AMCCBS #GCChat #CancerGenetics

Behind the scenes of an interview at #HESummit between Health Evolution’s Gabriel Perna and our CEO @FeyiOlopade: Stay tuned for a future story on how CancerIQ is successfully integrating #genomics into routine care!

A precision approach to prevention could “end cancer as we know it by preventing suffering and death for those at risk and by helping those not at risk avoid unnecessary tests and treatments,” according to National Cancer Institute: bit.ly/3zY4UUb #precisionprevention #oncology #genetics

Taha Jangda of HealthX Ventures leading great #CapTimesIdeaFest talk about what it will take to sustain innovation in the Madison area with Meghan Gaffney (she/her)🇺🇦 of @Veda_Data and Feyi Olopade of CancerIQ. Many thanks to HealthX for curating and sponsoring the panel!

“We can do a lot to treat patients in late stages & pour a ton of money into those treatments, but what’s going to save more lives from cancer is detecting it early or preventing it altogether,” our CEO Feyi Olopade tells Gabriel Perna Health Evolution. x.com/HealthEvolutio…

Fewer patients are getting screened for cancer as a result of the pandemic. CancerIQ Founder & CEO Feyi Olopade says that genomics-based screening assessments can provide health systems with a path forward to more effective cancer prevention. ow.ly/Sf8P50GeBS0

The mother (Olufunmilayo Olopade)-daughter (Feyi Olopade) team that launched CancerIQ is aiming to create easy-to-navigate cancer-based risk assessments, embedded into clinical workflow. How #genomics may be a path forward to more effective cancer prevention. ow.ly/h5qE50GdSzZ

In honor of #WomensHistoryMonth, we’d like to introduce our Head of People and Operations, Sharon Ray. Sharon helps lead growth at CancerIQ. #WomensHistoryMonth2022 #WomenEmpoweringWomen #Hiring

From gene sequencing to AI-enabled MRI and radiation therapy technology, meet the entrepreneurs changing the landscape of cancer for the better w/ Esther Dyson Emi Gal Feyi Olopade Dr Anthony Chang at #FIRE22 youtu.be/tuPIMX4NMBI

Brooklyn Nets director of scouting Matt Riccardi is joining the Dallas Mavericks in a senior front office role, sources tell ESPN. Riccardi spent 13 years with the Nets, advancing from an intern. He grew up in the Dallas area.

Looking forward to seeing familiar #GeneChat faces at #NSGC22 Genetic Counselors tonight and tomorrow in the Exhibition Hall. Excited to catch you up on our updated pedigree and productivity features. Come find CancerIQ at Booth 229!

Last selfie of #ASCO23 : with Feyi Olopade CancerIQ and Fay Hlubocky PhD MA FASCO . See you in Nara Japan in 2 weeks 🌏 for #MASCC23